106 related articles for article (PubMed ID: 7379362)
1. Design analyses of a new selective filtration system for removal of uremic toxins.
Smeby LC; Jørstad S; Wilderøe TE
Clin Nephrol; 1980 Mar; 13(3):125-32. PubMed ID: 7379362
[TBL] [Abstract][Full Text] [Related]
2. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
Jørstad S; Smeby LC; Widerøe TE; Berg KJ
Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
[TBL] [Abstract][Full Text] [Related]
3. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
[TBL] [Abstract][Full Text] [Related]
4. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
Jörstad S; Smeby LC; Wideröe TE; Berg KJ
Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney.
Jörstad S; Smeby LC; Wideröe TE
Artif Organs; 1981; 4 Suppl():98-103. PubMed ID: 7295103
[TBL] [Abstract][Full Text] [Related]
6. [Middle molecules removal. Beyond beta2-microglobulin].
Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
[TBL] [Abstract][Full Text] [Related]
7. Uremic toxins: a new focus on an old subject.
Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
[TBL] [Abstract][Full Text] [Related]
8. Selection of filters and evaluation in vitro of the selective dual filtration artificial kidney, SEDUFARK.
Svartaas TM; Smeby LC; Jørstad S; Naess TB; Widerøe TE; Holtz M
Artif Organs; 1982 May; 6(2):136-44. PubMed ID: 7125956
[TBL] [Abstract][Full Text] [Related]
9. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
[TBL] [Abstract][Full Text] [Related]
10. A new procedure for the removal of protein bound drugs and toxins.
Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
[TBL] [Abstract][Full Text] [Related]
11. An overview of uremic toxicity.
Vanholder RC; Glorieux GL
Hemodial Int; 2003 Apr; 7(2):156-61. PubMed ID: 19379356
[TBL] [Abstract][Full Text] [Related]
12. Relationship between uremic toxins and oxidative stress in patients with chronic renal failure.
Rutkowski P; Słominska EM; Szołkiewicz M; Aleksandrowicz E; Smolenski RT; Wołyniec W; Renke M; Wisterowicz K; Swierczynski J; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):243-8. PubMed ID: 17469035
[TBL] [Abstract][Full Text] [Related]
13. How can liver toxins be removed? Filtration and adsorption with the Prometheus system.
Vienken J; Christmann H
Ther Apher Dial; 2006 Apr; 10(2):125-31. PubMed ID: 16684213
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and clinical evidence for uremic toxicity.
Bouré T; Vanholder R
Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
[TBL] [Abstract][Full Text] [Related]
15. [Modelling and simulation of urea balance in a rat model on the condition of large intestine infusion analogous to the ultrafiltrate as a contribution to the development of an implantable intestinal hybrid kidney].
Schumann L; Dörp E; Wüstenberg PW; Schröder J; Falkenhagen D; Klinkmann H
Z Exp Chir Transplant Kunstliche Organe; 1988; 21(3):128-32. PubMed ID: 3407252
[TBL] [Abstract][Full Text] [Related]
16. [Uraemic toxins and cardiovascular diseases].
Oko A; Pawlaczyk K; Czekalski S
Przegl Lek; 2005; 62 Suppl 2():7-10. PubMed ID: 16623109
[TBL] [Abstract][Full Text] [Related]
17. Materials and design consideration for a compact artificial kidney.
Levine SN; LaCourse WC
J Biomed Mater Res; 1967 Jun; 1(2):275-84. PubMed ID: 5605703
[No Abstract] [Full Text] [Related]
18. Continuously functioning artificial nephron system: the promise of nanotechnology.
Nissenson AR; Ronco C; Pergamit G; Edelstein M; Watts R
Hemodial Int; 2005 Jul; 9(3):210-7. PubMed ID: 16191071
[TBL] [Abstract][Full Text] [Related]
19. Upflow anaerobic sludge blanket reactor--a review.
Bal AS; Dhagat NN
Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
Leypoldt JK
Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
